Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise

Med Sci Monit. 2024 Feb 1:30:e943911. doi: 10.12659/MSM.943911.

Abstract

In December 2023, the US Centers for Disease Control and Prevention (CDC) published the updated 2024 Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule, which is available online for access by the public and healthcare professionals. These new guidelines come at a time when the incidence of vaccine-preventable viral infections from SARS-CoV-2 (JN.1), respiratory syncytial virus (RSV), influenza, and measles are increasing in adults and children due to vaccine hesitancy, or non-compliance. This editorial aims to highlight the ongoing global health concerns for the consequences of increasing reports of vaccine-preventable infections, including SARS-CoV-2 (JN.1), influenza, RSV, and measles, to understand the causes of vaccine hesitancy, and introduce some public health measures that could improve vaccine uptake.

Publication types

  • Editorial

MeSH terms

  • Adult
  • COVID-19* / prevention & control
  • Child
  • Communicable Diseases*
  • Global Health
  • Humans
  • Influenza Vaccines*
  • Influenza, Human* / epidemiology
  • Measles* / epidemiology
  • Measles* / prevention & control
  • Respiratory Syncytial Viruses
  • SARS-CoV-2

Substances

  • Influenza Vaccines